The Association Between Malignant Otitis Externa and Diabetes Mellitus in Africa: A Systematic Review
- PMID: 37974885
- PMCID: PMC10645783
- DOI: 10.1007/s12070-023-03939-3
The Association Between Malignant Otitis Externa and Diabetes Mellitus in Africa: A Systematic Review
Abstract
Diabetes mellitus is one of the risk factors for malignant otitis externa. There are very few studies on the disease in Africa and there is a need to pool the prior studies to highlight the characteristics of the disease. The study type is a systematic review and the PRISMA guidelines were followed. Using the appropriate terms, relevant medical databases were systematically searched. Thirty-two studies met the eligibility criteria with a total sample size of 848, who were mainly elderly. Diabetes mellitus was present in 94% of the participants. Average duration of diabetes diagnosis in the participants was 12.4 years. The pooled HbA1c was 9.8%. The most common symptoms were otalgia (96.1%), otorrhoea (75.8%) and hearing loss (56.1%). Pseudomonas was the most common isolate (72%). Fluoroquinolones and the 3rd-generation cephalosporins were the preferred antibiotics. The pooled cure rate from antimicrobial usage was 76.2%. In addition to medications, 24.6% of the affected individuals required debridement. About 1.6% of the participants died from malignant otitis externa. Malignant otitis externa is associated with poorly controlled diabetes. Pseudomonas is the most common cause and a significant proportion gets cured with prolonged antibiotherapy.
Keywords: Africa; Complications; Diabetes mellitus; Malignant otitis externa; Systematic review.
© Association of Otolaryngologists of India 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors have no conflict of interest to declare.
Figures
Similar articles
-
Malignant otitis externa.J Craniofac Surg. 2012 Nov;23(6):1748-51. doi: 10.1097/SCS.0b013e31825e4d9a. J Craniofac Surg. 2012. PMID: 23147298
-
An emergency medicine-focused review of malignant otitis externa.Am J Emerg Med. 2020 Aug;38(8):1671-1678. doi: 10.1016/j.ajem.2020.04.083. Epub 2020 Apr 29. Am J Emerg Med. 2020. PMID: 32505469 Review.
-
Fungal Malignant Otitis Externa: A Systematic Review.Cureus. 2024 Oct 13;16(10):e71345. doi: 10.7759/cureus.71345. eCollection 2024 Oct. Cureus. 2024. PMID: 39534824 Free PMC article. Review.
-
Malignant Otitis Externa: A persistent challenge.Tunis Med. 2024 Aug 5;102(8):478-482. doi: 10.62438/tunismed.v102i8.4867. Tunis Med. 2024. PMID: 39129575 Free PMC article. English.
-
A rare cause of malignant otitis externa and skull base osteomyelitis.Br J Hosp Med (Lond). 2024 May 30;85(5):1-5. doi: 10.12968/hmed.2023.0421. Epub 2024 May 29. Br J Hosp Med (Lond). 2024. PMID: 38815968
Cited by
-
Evaluation of the clinical and radiological features of patients with Malignant otitis externa (MOE).BMC Infect Dis. 2025 Feb 26;25(1):277. doi: 10.1186/s12879-025-10637-8. BMC Infect Dis. 2025. PMID: 40000962 Free PMC article.
References
-
- Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(1 Suppl):S1–24. - PubMed
-
- Baoum SO, Mousa AAB, Alshammari MY, Alzaher ZS, Zahrani HM, Alhammad AH, et al. Epidemiology, risk factors and monitoring of acute otitis externa. Int J Commun Med Public Health. 2021;8(12):6155–6159.
-
- Wipperman J. Otitis externa. Prim Care. 2014;41(1):1–9. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous